Matching slides 110,387
Current window 3,181-3,210
Pages 3,680
Rows per page 30
Component: Source Noteclear collectionreset all

Component

3,181-3,210 of 110,387

filter-aware
08
The slide uses a structured table to present key drug development metrics.AbCellera | Investor Conference Presentation Deck | 14 slides · AbCellera
Conference presentation Investor relations 2 hits
20
Includes logos of partner/talent source institutions and photos of the team and lab facilities.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
33
The slide uses EEG power spectral density analysis to demonstrate target engagement and potential for a superior safety profile (less sedation) compared to standard benzodiazepines.ATAI | Investor Presentation Deck | 34 slides · atai Life Sciences
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
30
The slide presents clinical evidence linking AXL expression to poor patient outcomes in two different cohorts.BioAtla | Investor Presentation Deck | 55 slides · BioAtla
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction2 hits
38
Data cut date: 30Jun23. Includes events occurring in >=15% of patients or grade >=3 in >=3% of patients.BioAtla | Investor Presentation Deck | 55 slides · BioAtla
Pitch deck Investor relations 2 hits
25
The slide uses a combination of a grouped bar chart for unit economics and a three-column metric layout for platform synergies.Deliveroo | Investor Event Presentation Deck | 112 slides · Deliveroo
Conference presentation Investor relations Beat · Satisfaction2 hits
33
The slide uses dual-line charts to show the divergence between inflation and currency devaluation, highlighting the Q3 2023 inflection point.Delivery Hero | Results Presentation Deck | 37 slides · Delivery Hero
Conference presentation Investor relations 2 hits
08
TBA likely stands for Total Beverage Alcohol.Diageo | Results Presentation Deck | 39 slides · Diageo
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction2 hits
19
Includes footnotes regarding YOY growth consistency and additional liquidity sources.D-Wave | Investor Conference Presentation Deck | 20 slides · D-Wave
Conference presentation Investor relations Beat · Ultimate Achievement2 hits
08
Includes specific disclaimers regarding EPS calculation and asset impairment.Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · Impact & Next Steps2 hits
13
Uses a combination of SEM imagery for material changes and diagrams for structural/systemic improvements.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · Solution & ApproachLoop · Quick Win Big Bet2 hits
49
Includes RECIST 1.1 criteria reference and patient progression note.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations 2 hits
22
The slide uses a split-screen layout to contrast two key growth metrics.Etsy | Results Presentation Deck | 35 slides · Etsy
Conference presentation Investor relations 2 hits
04
The slide uses a high-contrast design with a list of sections where only the active section is fully opaque.Faraday Future | Results Presentation Deck | 38 slides · Faraday Future
Conference presentation Investor relations Beat · Humble Origins2 hits
14
FGI Industries | Investor Presentation Deck | 30 slidesFGI Industries | Investor Presentation Deck | 30 slides · FGI Industries
Pitch deck Investor relations Beat · SolutionLoop · Why Now2 hits
16
The slide compares clinical trial data from two different studies (Morris et al. 2017 and Hofman et al. 2018) to illustrate the efficacy of different PSMA-targeting agents.Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Competition2 hits
02
Fusion Pharmaceuticals | Investor Presentation Deck | 30 slidesFusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 2 hits
14
The slide contrasts a chemotherapy-based approach (SMDC) with a radioligand therapy (RLT) approach, highlighting the superior PSA response in the RLT cohort.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 2 hits
02
Hyperfine | Investor Presentation Deck | 22 slidesHyperfine | Investor Presentation Deck | 22 slides · Hyperfine
Pitch deck Investor relations 2 hits
17
Slide compares two generations of therapy; includes clinical metrics like cORR and mDOR.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · Traction2 hits
18
The chart demonstrates the mechanism of action: rapid cell expansion followed by clearance within 30 days, correlating with disease marker reduction.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations Beat · Traction2 hits
07
The slide uses clinical data to establish the biological rationale for the therapeutic approach.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction2 hits
15
The slide uses a bar chart to visualize effect sizes, with a supporting text box explaining the methodology and context.MindMed | Results Presentation Deck | 20 slides · MindMed
Conference presentation Investor relations Beat · Impact & Next Steps2 hits
20
Includes two distinct experimental setups: cell proliferation assays and mouse tumor growth models.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Loop · Quick Win Big Bet2 hits
11
The slide uses a split-screen comparison between UK market ranking improvements and German volume growth metrics.Oatly | Results Presentation Deck | 39 slides · Oatly
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet2 hits
63
The chart is a stacked bar representation of asset values.SoftBank | Investor Presentation Deck | 103 slides · SoftBank
Pitch deck Investor relations Beat · Satisfaction2 hits
27
The slide uses two distinct panels to explain complex ownership and loan structures, including specific financial figures for different fiscal periods.SoftBank | Results Presentation Deck | 100 slides · SoftBank
Conference presentation Investor relations Beat · Satisfaction2 hits
12
The slide uses a table to decompose the segment income, specifically detailing the components of investment losses across SVF1, SVF2, and LatAm Funds.SoftBank | Results Presentation Deck | 30 slides · SoftBank
Conference presentation Investor relations Beat · FinancialsLoop · Logic Chain2 hits
30
Uses a waterfall-style diagram to illustrate tax accounting logic.SoftBank | Results Presentation Deck | 30 slides · SoftBank
Conference presentation Investor relations 2 hits
49
The table provides a granular view of how net asset values are derived for Alibaba, SBKK, SVF1, SVF2, LatAm Funds, and Arm.SoftBank | Results Presentation Deck | 56 slides · SoftBank
Conference presentation Investor relations Loop · Mece Breakdown2 hits